All News about Intellia Thera CS
![](https://investorplace.com/wp-content/uploads/2019/07/esports1600-1.jpg)
![](https://investorplace.com/wp-content/uploads/2021/02/crispr-genetic-editing.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/16/aapharma_3.png?width=1200&height=800&fit=crop)
Intellia Therapeutics Posts Back To Back Positive Data From Gene Editing Therapies
September 16, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/16/aapharma_2.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2019/01/stock-gene-03-adobe.jpg)
![](https://www.investors.com/wp-content/uploads/2017/12/Stock-biotech-12-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_2459.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_24449.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/01/bz-pharma_4.jpg?width=1200&height=800&fit=crop)
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
September 01, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/01/bz-pharma_2.jpg?width=1200&height=800&fit=crop)
Intellia Gets FDA Orphan Drug Status For Hereditary Angioedema Candidate
September 01, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_2467.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For September 1, 2022
September 01, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_7966.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_25910.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/options_image_1909.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/24/image-macys.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/08/monkeypoxvax1600-2.png)
![](https://cdn.benzinga.com/files/images/story/2022/08/24/image30.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/05/price-prediction.jpg)
![](https://www.investors.com/wp-content/uploads/2022/01/Stock-pfizersign-05-adobe.jpg)
![](https://www.investors.com/wp-content/uploads/2017/11/Stock-Drugs-09-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/08/04/image-crocs.jpg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2022/01/Stock-intelliatherapeutics-01-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/08/04/cells-gdd37bc5d2_1920.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2020/03/gene_editing_c_1600.jpg)
![](https://investorplace.com/wp-content/uploads/2022/03/cathie-wood-stocks-1600.png)
![](https://cdn.benzinga.com/files/images/story/2022/options_image_1631.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2020/03/gene_editing_a_1600.jpg)
![](https://investorplace.com/wp-content/uploads/2020/03/gene_editing_c_1600.jpg)
![](https://www.investors.com/wp-content/uploads/2017/10/stock-biotech-02-adobe.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.